The Role of Prostaglandin E Receptor Subtypes (EP1, EP2, EP3, and EP4) in Bone Resorption: An Analysis Using Specific Agonists for the Respective EPs
Tetsuo Suzawa(Showa University), Tatsuo Suda(SHOWA Medical University), Shuh Narumiya(Kyoto University), Atsushi Ichikawa(SHOWA Medical University), Yukihiko Sugimoto(SHOWA Medical University), Masaki Inada(Tokyo University of Agriculture and Technology), Takayuki Maruyama(SHOWA Medical University), Chisato Miyaura(Showa University), Fumitaka Ushikubi(Asahikawa Medical College Hospital)
Cited by 391
Related Papers
Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL
|Proceedings of the National Academy of Sciences|1998|4.3k
Tumor Necrosis Factor α Stimulates Osteoclast Differentiation by a Mechanism Independent of the Odf/Rankl–Rank Interaction
|The Journal of Experimental Medicine|2000|1.3k
OSTEOBLASTIC CELLS ARE INVOLVED IN OSTEOCLAST FORMATION
|Endocrinology|1988|945
Regulation of Osteoblast Differentiation Mediated by Bone Morphogenetic Proteins, Hedgehogs, and Cbfa1
|Endocrine Reviews|2000|665
Interleukin-6 and soluble interleukin-6 receptors in the synovial fluids from rheumatoid arthritis patients are responsible for osteoclast-like cell formation
|Journal of Bone and Mineral Research|1996|548